STERIS plc
STE
Classement en actions
#1068
STERIS plc provides infection prevention products and services in the United... STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Prix de l'action
$223.69
Capitalisation boursière
$21.81B
Changement (1 jour)
0.62%
Changement (1 an)
-7.65%
Pays
IE
Échange STERIS plc (STE)
Catégorie
Healthcare
Ratio P/E pour STERIS plc (STE)
Ratio P/E au October 2026 TTM : 26.50
Selon les derniers rapports financiers et le cours de l'action de STERIS plc, le ratio P/E actuel (TTM) est de 26.50. À la fin de l’année 2024, le P/E de l’entreprise était de 57.73.
Historique du ratio P/E pour STERIS plc de 2000 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 26.50 | -27.11% |
| 2025 | 36.35 | -37.03% |
| 2024 | 57.73 | -67.60% |
| 2023 | 178.19 | 84.29% |
| 2022 | 96.69 | 136.75% |
| 2021 | 40.84 | 40.30% |
| 2020 | 29.11 | -17.88% |
| 2019 | 35.45 | 29.90% |
| 2018 | 27.29 | -49.46% |
| 2017 | 53.99 | 19.05% |
| 2016 | 45.35 | 46.71% |
| 2015 | 30.91 | 42.11% |
| 2014 | 21.75 | 45.00% |
| 2013 | 15.00 | 10.64% |
| 2012 | 13.56 | -66.07% |
| 2011 | 39.96 | 159.24% |
| 2010 | 15.41 | 24.68% |
| 2009 | 12.36 | -43.79% |
| 2008 | 21.99 | 4.33% |
| 2007 | 21.08 | -12.03% |
| 2006 | 23.96 | 17.67% |
| 2005 | 20.36 | 7.34% |
| 2004 | 18.97 | -17.33% |
| 2003 | 22.95 | -27.34% |
| 2002 | 31.58 | -95.52% |
| 2001 | 705.00 | 1,000.49% |
| 2000 | 64.06 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| 20.66 | -22.01% |
KR
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.